RRIDs were included in the Journal for ImmunoTherapy of Cancer paper "CEA expression heterogeneity and plasticity confer…" (https://t.co/qstr5Yfkah). Thank you for making your #methodsmatter. #reproducibility
RRIDs were included in the Journal for ImmunoTherapy of Cancer paper "untitled" (https://t.co/qstr5Yfkah). We appreciate the author's support of reproducibility. #RRID #reproducibility
The authors of "untitled" (https://t.co/qstr5Yfkah) included RRIDs in their paper! We appreciate the author's support of reproducibility. #ReproducibleResearch #OpenScience
The authors of "untitled" (https://t.co/qstr5Yfkah) included RRIDs in their paper! Thank you for making your #methodsmatter. #OpenScience
The authors of "untitled" (https://t.co/qstr5Yfkah) included RRIDs in their paper! RRIDs like this improve reproducibility in scientific research. #RRID #methodsmatter
RT @sitcancer: #JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy…
#JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids https://t.co/V5XK42eylv https://t.co/eeYIciVJ7v
RT @sitcancer: #JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy…
#JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids https://t.co/V5XK42eylv https://t.co/EpnaELo9Lf
RT @organoidscience: 🔓 From the @MarcoGerlinger lab: Carcino-Embryonic Antigen (CEA) expression heterogeneity & plasticity confer resistanc…
🔓 From the @MarcoGerlinger lab: Carcino-Embryonic Antigen (CEA) expression heterogeneity & plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab in patient-derived colorectal cancer #organoids. https://t.co/PyF
New from #CR_UK https://t.co/WDSGOGEASY CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids
#JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids https://t.co/V5XK42eylv https://t.co/PRhbw1M4oc
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
RT @VHIO: Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help…
Researchers at @ICR_London have discovered the mechanism by which certain tumours evade #Immunotherapy. This finding could help #Oncologists determine which patients will respond to immunotherapy. Via @BioMedCentral https://t.co/fweRteqK1h
This is an important conclusion for targeting tumor-associated antigens (TAA)!! Heterogeneity and plasticity of CEA expression appear to confer low drug sensitivity. https://t.co/hmS1nSXhUm
RT @MarcoGerlinger: Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrec…
RT @Intestinal_Cell: Patient-derived #ColorectalCancer #organoids were shown to have low cibisatamab sensitivity. Pharmacological inhibiti…
Patient-derived #ColorectalCancer #organoids were shown to have low cibisatamab sensitivity. Pharmacological inhibition of the WNT/β-catenin pathway may be a rational combination for sensitization. https://t.co/qwTODxEq4Q @MarcoGerlinger @royalmarsdenNHS
RT @sitcancer: New #JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunother…
RT @MarcoGerlinger: Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrec…
New #JITC Research: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids https://t.co/V5XK42eylv https://t.co/MN9roTqMPn
RT @MarcoGerlinger: Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrec…
RT @MarcoGerlinger: Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrec…
RT @MarcoGerlinger: Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrec…
Just out in JITC : Plasticity of CEA expression in patient-derived CRC organoids influences response to T cell redicrecting immunotherapy. PDO + T cell co-culture is promising for IO in vitro studies! https://t.co/eOETQ5bRXW https://t.co/fRfWlsxBn5
RT @ICR_London: The study was published, #OpenAccess, in the Journal for Immunotherapy of Cancer: CEA expression heterogeneity and plastic…
RT @ICR_London: The study was published, #OpenAccess, in the Journal for Immunotherapy of Cancer: CEA expression heterogeneity and plastic…
The study was published, #OpenAccess, in the Journal for Immunotherapy of Cancer: CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab… https://t.co/ftBjOdgg7I